Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $45.00.

A number of brokerages have recently issued reports on ASTH. Needham & Company LLC lifted their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a report on Friday, May 8th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $37.00 to $50.00 in a report on Tuesday, May 26th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a report on Friday, May 8th. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. Finally, TD Cowen lifted their price objective on shares of Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a report on Tuesday, May 12th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Signaturefd LLC lifted its position in shares of Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares in the last quarter. Strs Ohio bought a new position in shares of Astrana Health during the fourth quarter valued at about $40,000. Tower Research Capital LLC TRC lifted its position in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares in the last quarter. Finally, State of Wyoming bought a new position in shares of Astrana Health during the second quarter valued at about $132,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Stock Up 3.0%

Shares of NASDAQ ASTH opened at $37.80 on Friday. The stock has a market capitalization of $2.11 billion, a P/E ratio of 61.97 and a beta of 1.00. The company has a 50-day moving average price of $33.15 and a 200-day moving average price of $26.83. Astrana Health has a 1 year low of $18.08 and a 1 year high of $39.93. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The business’s revenue was up 55.6% on a year-over-year basis. During the same period last year, the company earned $0.42 earnings per share. On average, equities research analysts forecast that Astrana Health will post 1.25 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.